Studies in nonmuscle cells have demonstrated that Ca2؉ / calmodulin-dependent protein kinase kinases (CaMKKs) are upstream regulators of AMP-activated protein kinase (AMPK) and Akt. In skeletal muscle, activation of AMPK and Akt has been implicated in the regulation of glucose uptake. The objective of this study was to determine whether CaMKK␣ regulates skeletal muscle glucose uptake, and whether it is dependent on AMPK and/or Akt activation. Expression vectors containing constitutively active CaMKK␣ (caCaMKK␣) or empty vector were transfected into mouse muscles by in vivo electroporation. After 2 weeks, caCaMKK␣ was robustly expressed and increased CaMKI (Thr 177/180 ) phosphorylation, a known CaMKK substrate. In muscles from wild-type mice, caCaMKK␣ increased in vivo [ 3 H]-2-deoxyglucose uptake 2.5-fold and AMPK␣1 and -␣2 activities 2.5-fold. However, in muscles from AMPK␣2 inactive mice (AMPK␣2i), caCaMKK␣ did not increase AMPK␣1 or -␣2 activities, but it did increase glucose uptake 2.5-fold, demonstrating that caCaMKK␣ stimulates glucose uptake independent of AMPK. Akt (Thr 308 ) phosphorylation was not altered by CaMKK␣, and caCaMKK␣ plus insulin stimulation did not increase the insulin-induced phosphorylation of Akt (Thr 308 ). These results suggest that caCaMKK␣ stimulates glucose uptake via insulin-independent signaling mechanisms. To assess the role of CaMKK in contraction-stimulated glucose uptake, isolated muscles were treated with or without the CaMKK inhibitor STO-609 and then electrically stimulated to contract. Contraction increased glucose uptake 3.5-fold in muscles from both wild-type and AMPK␣2i mice, but STO-609 significantly decreased glucose uptake (ϳ24%) only in AMPK␣2i mice. Collectively, these results implicate CaMKK␣ in the regulation of skeletal muscle glucose uptake independent of AMPK and Akt activation. Diabetes 56:1403-1409, 2007 I n the U.S., 90 -95% of all diagnosed cases of diabetes are classified as type 2 diabetes (1), a form of diabetes where target tissues such as skeletal muscle do not respond properly to insulin. In these patients, insulin-dependent signaling mechanisms regulating skeletal muscle glucose uptake are impaired (2). Importantly, insulin-independent mechanisms, including muscle contraction or exercise-mediated mechanisms for regulating glucose uptake, remain intact (3). Thus, elucidation of the signaling pathways governing contractioninduced increases in skeletal muscle glucose uptake may provide new pharmacological targets for the treatment of individuals with type 2 diabetes.Muscle contraction is a multifactorial process involving changes in energy status (i.e., increased AMP-to-ATP ratio), increases in intracellular Ca 2ϩ levels, stretch, etc., and it is likely that multiple signaling pathways act to increase plasma membrane GLUT4 transporters and glucose uptake. Studies using the AMP analog, 5-aminoimidazole-4-carboxamide-1--D-ribofuranotide (AICAR), have demonstrated that activation of AMP-activated protein kinase (AMPK) is positively correlated with an i...